BMY-28121, a new antitumor antibiotic
    13.
    发明授权
    BMY-28121, a new antitumor antibiotic 失效
    BMY-28121,一种新的抗肿瘤抗生素

    公开(公告)号:US4935362A

    公开(公告)日:1990-06-19

    申请号:US31955

    申请日:1987-03-30

    IPC分类号: C07D487/04 C12P17/18

    摘要: A new antitumor antibiotic designated herein as BMY-28121 is produced by fermentation of Streptomyces albus strain K7331-113 (ATCC 39897). BMY-28121, which may be recovered from the fermentation broth in either its natural free hydroxy form (BMY-28121A) or methyl ether form (BMY-28121B), inhibits gram-positive bacteria and anaerobes and inhibits the growth of mammalian tumors such as P-388 leukemia, L-1210 leukemia and B16 melanoma.

    摘要翻译: 本文命名为BMY-28121的新抗肿瘤抗生素是通过发酵链霉菌株K7331-113(ATCC 39897)产生的。 可以从其天然游离羟基形式(BMY-28121A)或甲基醚形式(BMY-28121B)的发酵液中回收的BMY-28121抑制革兰氏阳性菌和厌氧菌,并抑制哺乳动物肿瘤的生长,例如 P-388白血病,L-1210白血病和B16黑素瘤。

    BMY-28121, a new antitumor antibiotic
    14.
    发明授权
    BMY-28121, a new antitumor antibiotic 失效
    BMY-28121,一种新的抗肿瘤抗生素

    公开(公告)号:US4683230A

    公开(公告)日:1987-07-28

    申请号:US704973

    申请日:1985-02-25

    摘要: A new antitumor antibiotic designated herein as BMY-28121 is produced by fermentation of Streptomyces albus strain K731-113 (ATCC 39897). BMY-28121, which may be recovered from the fermentation broth in either its natural free hydroxy form (BMY-28121A) or methyl ether form (BMY-28121B), inhibits gram-positive bacteria and anaerobes and inhibits the growth of mammalian tumors such as P-388 leukemia, L-1210 leukemia and B16 melanoma.

    摘要翻译: 本文命名为BMY-28121的新型抗肿瘤抗生素通过Streptomyces albus菌株K731-113(ATCC 39897)的发酵产生。 可以从其天然游离羟基形式(BMY-28121A)或甲基醚形式(BMY-28121B)的发酵液中回收的BMY-28121抑制革兰氏阳性菌和厌氧菌,并抑制哺乳动物肿瘤的生长,例如 P-388白血病,L-1210白血病和B16黑素瘤。